市場調査レポート
商品コード
1425446

医療用医薬品の世界市場レポート 2024年

Ethical Pharmaceuticals Global Market Report 2024

出版日: 受注後更新 | 発行: The Business Research Company | ページ情報: 英文 200 Pages | 納期: 2~10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=158.31円
医療用医薬品の世界市場レポート 2024年
出版日: 受注後更新
発行: The Business Research Company
ページ情報: 英文 200 Pages
納期: 2~10営業日
  • 全表示
  • 概要
  • 目次
概要

医療用医薬品の市場規模は近年急速に拡大しています。2023年の64億3,000万米ドルから2024年には72億3,000万米ドルへと、CAGR12.5%で拡大します。これまでの成長の背景には、医薬品の技術革新と発見の進展、規制の枠組みの進化、伝統的な薬物療法の継続使用、慢性疾患の流行、研究開発への多額の投資があります。

慢性疾患の増加は、医療用医薬品市場の成長を促進する主要要因となっています。糖尿病、がん、心臓病などの慢性疾患は、継続的な医療と長期的な治療を必要とするため、医療用医薬品の需要を押し上げています。例えば、米国疾病予防管理センター(CDC)の報告によると、米国では2019年時点で1億3,000万人以上が糖尿病または糖尿病予備軍であることが明らかになっています。さらに、慢性疾患は2020年から57%増加し、世界の年間死亡者数の71%に寄与すると推定されています。この動向は、慢性疾患有病率の上昇による医療用医薬品の需要拡大が期待されることを裏付けています。

2023年の医療用医薬品市場シェアでは北米が最大地域でした。アジア太平洋は、予測期間において最も急成長する地域となる見込みです。医療用医薬品市場レポートの対象地域は、アジア太平洋、西欧、中東欧、北米、南米、中東・アフリカです。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

  • 高インフレが市場に与える影響
  • ウクライナ・ロシア戦争が市場に与える影響
  • COVID-19による市場への影響

第5章 世界市場規模と成長

  • 世界の医療用医薬品市場の促進要因と抑制要因
    • 市場促進要因
    • 市場抑制要因
  • 世界の医療用医薬品市場規模実績と成長、2018~2023年
  • 世界の医療用医薬品市場規模と成長予測、2023~2028年、2033年

第6章 市場セグメンテーション

  • 世界の医療用医薬品市場、タイプ別セグメンテーション、実績と予測、2018~2023年、2023~2028年、2033年
  • 脂質調節剤
  • 麻薬性鎮痛薬
  • ACE阻害剤
  • 呼吸器官
  • 利尿薬
  • カルシウム拮抗薬
  • ホルモン避妊薬
  • ペニシリン
  • ビタミン
  • 世界の医療用医薬品市場、流通チャネル別セグメンテーション、実績と予測、2018~2023年、2023~2028年、2033年
  • 病院薬局
  • 小売薬局
  • その他
  • 世界の医療用医薬品市場、用途別セグメンテーション、実績と予測、2018~2023年、2023~2028年、2033年
  • 病院とクリニック
  • 製薬会社

第7章 地域と国の分析

  • 世界の医療用医薬品市場、地域別、実績と予測、2018~2023年、2023~2028年、2033年
  • 世界の医療用医薬品市場、国別、実績と予測、2018~2023年、2023~2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

  • 医療用医薬品市場の競合情勢
  • 医療用医薬品市場企業プロファイル
    • Johnson &Johnson Services Inc.
    • GlaxoSmithKline plc
    • Teva Pharmaceutical Industries Ltd.
    • Merck &Co. Inc.
    • Novartis AG

第31章 競合ベンチマーキング

第32章 競合ダッシュボード

第33章 主要な合併と買収

第34章 将来の展望と潜在性分析

第35章 付録

目次
Product Code: r12677

Ethical Pharmaceuticals Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on ethical pharmaceuticals market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for ethical pharmaceuticals? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The ethical pharmaceuticals market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

  • 1) By Type: Lipid Regulators; Narcotic Analgesics; ACE Inhibitors; Respiratory Agents; Diuretics; Calcium Antagonists; Hormonal Contraceptives; Penicillin; Vitamin; Minerals
  • 2) By Distribution Channel: Hospital Pharmacy; Retail Pharmacies; Other Distribution Channels
  • 3) By Application: Hospitals And Clinics; Pharmaceutical Company
  • Companies Mentioned: Johnson & Johnson Services Inc.; GlaxoSmithKline PLC; Teva Pharmaceutical Industries Ltd.; Merck & Co. Inc.; Novartis AG
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Executive Summary

Ethical pharmaceuticals refer to medications that are strictly dispensed under a doctor's prescription through a registered pharmacist, as they are regulated substances overseen by specific regulatory bodies.

The primary categories within ethical pharmaceutical markets encompass lipid regulators, narcotic analgesics, ACE inhibitors, respiratory agents, diuretics, calcium antagonists, hormonal contraceptives, penicillin, vitamins, and minerals. Lipid regulators, for example, alter lipid metabolism and are crucial in managing cardiovascular health, particularly in reducing the risk of events like heart attacks and strokes. These include substances like HMG-CoA reductase inhibitors, commonly known as statins. Distribution channels for these pharmaceuticals involve hospital and retail pharmacies, among others. They find applications across various healthcare settings such as hospitals, clinics, and pharmaceutical companies, serving as essential components in managing different health conditions and improving overall well-being.

The ethical pharmaceutical market research report is one of a series of new reports from The Business Research Company that provides ethical pharmaceutical market statistics, including ethical pharmaceutical industry global market size, regional shares, competitors with an ethical pharmaceutical market share, detailed ethical pharmaceutical market segments, market trends and opportunities, and any further data you may need to thrive in the ethical pharmaceutical industry. This ethical pharmaceutical market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The ethical pharmaceuticals market size has grown rapidly in recent years. It will grow from $6.43 billion in 2023 to $7.23 billion in 2024 at a compound annual growth rate (CAGR) of 12.5%. Historical growth can be attributed to advancements in drug innovation and discovery, the evolution of regulatory frameworks, the continued use of traditional drug therapies, the prevalence of chronic diseases, and substantial investments in research and development.

The ethical pharmaceuticals market size is expected to see rapid growth in the next few years. It will grow to $11.77 billion in 2028 at a compound annual growth rate (CAGR) of 13.0%. The anticipated growth in the forecast period is propelled by advancements in precision medicine, the evolution of biologics and advanced therapies, continuous innovations in biopharmaceuticals, shifts in the regulatory landscape, and the integration of digital health solutions. Major trends expected during this period include a dedicated focus on precision medicine, the digitization of healthcare and expansion of remote care services, the development of precision drug delivery systems, leveraging real-world evidence in clinical trials, and fostering collaborative research through strategic partnerships.

The increasing prevalence of chronic diseases stands as a primary driver propelling the growth of the ethical pharmaceutical market. Chronic conditions, such as diabetes, cancer, and heart disease, require ongoing medical care and long-term treatment, thereby boosting the demand for ethical pharmaceutical drugs. For instance, reports from the Centers for Disease Control and Prevention (CDC) reveal that over 130 million individuals in the US have diabetes or prediabetes as of 2019. Moreover, chronic diseases are estimated to increase by 57% from 2020, contributing to 71% of global annual fatalities. This trend underlines the expected growth in demand for ethical pharmaceuticals due to rising chronic disease prevalence.

The surge in healthcare expenditures is anticipated to drive the growth of the ethical pharmaceutical market. Increased healthcare spending leads to advancements in patient access to high-quality pharmaceutical treatments. This upsurge in healthcare expenses aligns with the ethical pursuit of providing quality medical care. For instance, in 2021, healthcare spending in the United States rose by 2.7% to $12,914 per person, totaling $4.3 trillion. This increase signifies the potential for a corresponding rise in demand for ethical pharmaceuticals.

Technological advancements are gaining prominence in the ethical pharmaceutical market, with major companies introducing innovative drugs like Sugmadex. BDR Pharma and Varenyam Healthcare, India-based pharmaceutical companies, jointly launched Sugmadex, a pioneering reversal agent featuring unique beta-cyclodextrin neuromuscular block (NMB) reversal properties. Sugmadex aims to address current anesthetic practice limitations and is available in single-dose vial sizes of 2 and 5 milliliters.

Major companies in the ethical pharmaceutical market are intensifying their focus on procurement programs to enhance their competitive position. GlaxoSmithKline PLC, a UK-based pharmaceutical company, introduced a Sustainable Procurement Programme for its suppliers, slated to commence in 2023. This initiative aims to minimize the environmental impact of the pharmaceutical industry's supply chain by encouraging suppliers to act on carbon reduction, sustainable sourcing, waste management, and deforestation-free materials, acknowledging the resource-intensive nature of pharmaceutical manufacturing processes.

In March 2022, Pfizer, a leading US-based pharmaceutical company, finalized the acquisition of Arena Pharmaceuticals for a substantial $6.7 billion. This strategic move is geared towards leveraging Arena Pharmaceuticals' pipeline to bolster Pfizer's portfolio in the field of inflammation and immunology therapeutics. The acquisition aims to enhance Pfizer's research and development efforts, focusing on advancements that could significantly impact the lives of individuals grappling with immuno-inflammatory diseases. Arena Pharmaceuticals, also based in the USA, brings valuable assets and expertise in the pharmaceutical domain. Pfizer's acquisition of Arena Pharmaceuticals is poised to amplify its capabilities and commitment to pioneering treatments in the realm of immuno-inflammatory diseases, fostering transformative developments for patients globally.

Major companies operating in the ethical pharmaceuticals market report are Johnson & Johnson Services Inc., GlaxoSmithKline PLC, Teva Pharmaceutical Industries Ltd., Merck & Co. Inc., Novartis AG, AstraZeneca PLC, Bristol-Myers Squibb Company, Eli Lilly and Company, Mylan NV, Pfizer Inc., Sanofi S.A., AbbVie Inc., Amgen Inc., Biogen Inc., Boehringer Ingelheim International GmbH, Celgene Corporation, Gilead Sciences Inc., Novo Nordisk A/S, Regeneron Pharmaceuticals Inc., Roche Holding AG, Takeda Pharmaceutical Company Limited, Abbott Laboratories, Bayer AG, Daiichi Sankyo Company Limited, Eisai Co. Ltd., Ipsen Biopharmaceuticals Inc., Kyowa Kirin Co. Ltd., Mallinckrodt Pharmaceuticals, Sun Pharmaceutical Industries Ltd., Amarin Corporation PLC, Vertex Pharmaceuticals Incorporated, and Aimmune Therapeutics Inc.

North America was the largest region in the ethical pharmaceutical market share in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the ethical pharmaceuticals market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the ethical pharmaceuticals market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The ethical pharmaceutical market includes revenues earned by entities from pharmaceutical commodities and services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Table of Contents

1. Executive Summary

2. Ethical Pharmaceuticals Market Characteristics

3. Ethical Pharmaceuticals Market Trends And Strategies

4. Ethical Pharmaceuticals Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Ethical Pharmaceuticals Market Size and Growth

  • 5.1. Global Ethical Pharmaceuticals Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Ethical Pharmaceuticals Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Ethical Pharmaceuticals Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Ethical Pharmaceuticals Market Segmentation

  • 6.1. Global Ethical Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Lipid Regulators
  • Narcotic Analgesics
  • ACE Inhibitors
  • Respiratory Agents
  • Diuretics
  • Calcium Antagonists
  • Hormonal Contraceptives
  • Penicillin
  • Vitamin
  • 6.2. Global Ethical Pharmaceuticals Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hospital Pharmacy
  • Retail Pharmacies
  • Other Distribution Channels
  • 6.3. Global Ethical Pharmaceuticals Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hospitals And Clinics
  • Pharmaceutical Company

7. Ethical Pharmaceuticals Market Regional And Country Analysis

  • 7.1. Global Ethical Pharmaceuticals Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Ethical Pharmaceuticals Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Ethical Pharmaceuticals Market

  • 8.1. Asia-Pacific Ethical Pharmaceuticals Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Ethical Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Ethical Pharmaceuticals Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Ethical Pharmaceuticals Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Ethical Pharmaceuticals Market

  • 9.1. China Ethical Pharmaceuticals Market Overview
  • 9.2. China Ethical Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Ethical Pharmaceuticals Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Ethical Pharmaceuticals Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Ethical Pharmaceuticals Market

  • 10.1. India Ethical Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Ethical Pharmaceuticals Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Ethical Pharmaceuticals Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Ethical Pharmaceuticals Market

  • 11.1. Japan Ethical Pharmaceuticals Market Overview
  • 11.2. Japan Ethical Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Ethical Pharmaceuticals Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Ethical Pharmaceuticals Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Ethical Pharmaceuticals Market

  • 12.1. Australia Ethical Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Ethical Pharmaceuticals Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Ethical Pharmaceuticals Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Ethical Pharmaceuticals Market

  • 13.1. Indonesia Ethical Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Ethical Pharmaceuticals Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Ethical Pharmaceuticals Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Ethical Pharmaceuticals Market

  • 14.1. South Korea Ethical Pharmaceuticals Market Overview
  • 14.2. South Korea Ethical Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Ethical Pharmaceuticals Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Ethical Pharmaceuticals Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Ethical Pharmaceuticals Market

  • 15.1. Western Europe Ethical Pharmaceuticals Market Overview
  • 15.2. Western Europe Ethical Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Ethical Pharmaceuticals Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Ethical Pharmaceuticals Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Ethical Pharmaceuticals Market

  • 16.1. UK Ethical Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Ethical Pharmaceuticals Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Ethical Pharmaceuticals Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Ethical Pharmaceuticals Market

  • 17.1. Germany Ethical Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Ethical Pharmaceuticals Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Ethical Pharmaceuticals Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Ethical Pharmaceuticals Market

  • 18.1. France Ethical Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Ethical Pharmaceuticals Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Ethical Pharmaceuticals Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Ethical Pharmaceuticals Market

  • 19.1. Italy Ethical Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Ethical Pharmaceuticals Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Ethical Pharmaceuticals Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Ethical Pharmaceuticals Market

  • 20.1. Spain Ethical Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Ethical Pharmaceuticals Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Ethical Pharmaceuticals Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Ethical Pharmaceuticals Market

  • 21.1. Eastern Europe Ethical Pharmaceuticals Market Overview
  • 21.2. Eastern Europe Ethical Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Ethical Pharmaceuticals Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Ethical Pharmaceuticals Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Ethical Pharmaceuticals Market

  • 22.1. Russia Ethical Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Ethical Pharmaceuticals Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Ethical Pharmaceuticals Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Ethical Pharmaceuticals Market

  • 23.1. North America Ethical Pharmaceuticals Market Overview
  • 23.2. North America Ethical Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Ethical Pharmaceuticals Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Ethical Pharmaceuticals Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Ethical Pharmaceuticals Market

  • 24.1. USA Ethical Pharmaceuticals Market Overview
  • 24.2. USA Ethical Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Ethical Pharmaceuticals Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Ethical Pharmaceuticals Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Ethical Pharmaceuticals Market

  • 25.1. Canada Ethical Pharmaceuticals Market Overview
  • 25.2. Canada Ethical Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Ethical Pharmaceuticals Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Ethical Pharmaceuticals Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Ethical Pharmaceuticals Market

  • 26.1. South America Ethical Pharmaceuticals Market Overview
  • 26.2. South America Ethical Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Ethical Pharmaceuticals Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Ethical Pharmaceuticals Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Ethical Pharmaceuticals Market

  • 27.1. Brazil Ethical Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Ethical Pharmaceuticals Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Ethical Pharmaceuticals Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Ethical Pharmaceuticals Market

  • 28.1. Middle East Ethical Pharmaceuticals Market Overview
  • 28.2. Middle East Ethical Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Ethical Pharmaceuticals Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Ethical Pharmaceuticals Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Ethical Pharmaceuticals Market

  • 29.1. Africa Ethical Pharmaceuticals Market Overview
  • 29.2. Africa Ethical Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Ethical Pharmaceuticals Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Ethical Pharmaceuticals Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Ethical Pharmaceuticals Market Competitive Landscape And Company Profiles

  • 30.1. Ethical Pharmaceuticals Market Competitive Landscape
  • 30.2. Ethical Pharmaceuticals Market Company Profiles
    • 30.2.1. Johnson & Johnson Services Inc.
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. GlaxoSmithKline plc
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Teva Pharmaceutical Industries Ltd.
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Merck & Co. Inc.
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Novartis AG
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Global Ethical Pharmaceuticals Market Competitive Benchmarking

32. Global Ethical Pharmaceuticals Market Competitive Dashboard

33. Key Mergers And Acquisitions In The Ethical Pharmaceuticals Market

34. Ethical Pharmaceuticals Market Future Outlook and Potential Analysis

  • 34.1 Ethical Pharmaceuticals Market In 2028 - Countries Offering Most New Opportunities
  • 34.2 Ethical Pharmaceuticals Market In 2028 - Segments Offering Most New Opportunities
  • 34.3 Ethical Pharmaceuticals Market In 2028 - Growth Strategies
    • 34.3.1 Market Trend Based Strategies
    • 34.3.2 Competitor Strategies

35. Appendix

  • 35.1. Abbreviations
  • 35.2. Currencies
  • 35.3. Historic And Forecast Inflation Rates
  • 35.4. Research Inquiries
  • 35.5. The Business Research Company
  • 35.6. Copyright And Disclaimer